182 related articles for article (PubMed ID: 8088323)
21. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
Guéry JC; Sette A; Appella E; Adorini L
J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
[TBL] [Abstract][Full Text] [Related]
22. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma.
Frandji P; Oskéritzian C; Cacaraci F; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
J Immunol; 1993 Dec; 151(11):6318-28. PubMed ID: 8245470
[TBL] [Abstract][Full Text] [Related]
23. Weak base amines can inhibit class I MHC-restricted antigen presentation.
Michalek MT; Benacerraf B; Rock KL
J Immunol; 1991 Jan; 146(2):449-56. PubMed ID: 1987272
[TBL] [Abstract][Full Text] [Related]
24. Freshly isolated mouse 4F7+ splenic dendritic cells process and present exogenous antigens to T cells.
Mohamadzadeh M; Pavlidou A; Enk A; Knop J; Rüde E; Gradehandt G
Eur J Immunol; 1994 Dec; 24(12):3170-4. PubMed ID: 7805745
[TBL] [Abstract][Full Text] [Related]
25. Normal B cells fail to secrete interleukin-12.
Guéry JC; Ria F; Galbiati F; Adorini L
Eur J Immunol; 1997 Jul; 27(7):1632-9. PubMed ID: 9247571
[TBL] [Abstract][Full Text] [Related]
26. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo.
Böhm W; Schirmbeck R; Elbe A; Melber K; Diminky D; Kraal G; van Rooijen N; Barenholz Y; Reimann J
J Immunol; 1995 Oct; 155(7):3313-21. PubMed ID: 7561024
[TBL] [Abstract][Full Text] [Related]
27. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.
Rock KL; Rothstein L; Gamble S; Fleischacker C
J Immunol; 1993 Jan; 150(2):438-46. PubMed ID: 8419476
[TBL] [Abstract][Full Text] [Related]
28. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
Adorini L; Ullrich SJ; Appella E; Fuchs S
Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
[TBL] [Abstract][Full Text] [Related]
29. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
St Pierre Y; Watts TH
J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE
Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881
[TBL] [Abstract][Full Text] [Related]
31. T cell activation by processed antigen is equally blocked by I-E and I-A-restricted immunodominant peptides.
Lakey EK; Casten LA; Anderson MS; Smolenski LA; Smith JA; Margoliash E; Pierce SK
Eur J Immunol; 1987 Nov; 17(11):1605-9. PubMed ID: 3500065
[TBL] [Abstract][Full Text] [Related]
32. Rapid constitutive generation of a specific peptide-MHC class II complex from intact exogenous protein in immature murine dendritic cells.
Colledge L; Bennett CL; Reay PA; Blackburn CC
Eur J Immunol; 2002 Nov; 32(11):3246-55. PubMed ID: 12555670
[TBL] [Abstract][Full Text] [Related]
33. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
Matousek MP; Nedrud JG; Harding CV
J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
[TBL] [Abstract][Full Text] [Related]
34. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
Snider DP; Segal DM
J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
[TBL] [Abstract][Full Text] [Related]
35. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
Kern DE; Klarnet JP; Jensen MC; Greenberg PD
J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
[TBL] [Abstract][Full Text] [Related]
36. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells.
Svensson M; Stockinger B; Wick MJ
J Immunol; 1997 May; 158(9):4229-36. PubMed ID: 9126984
[TBL] [Abstract][Full Text] [Related]
37. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
[TBL] [Abstract][Full Text] [Related]
38. Engagement of the B lymphocyte antigen receptor induces presentation of intrinsic immunoglobulin peptides on major histocompatibility complex class II molecules.
Bartnes K; Hannestad K
Eur J Immunol; 1997 May; 27(5):1124-30. PubMed ID: 9174601
[TBL] [Abstract][Full Text] [Related]
39. Intrathymic presentation by dendritic cells and macrophages: their role in selecting T cells with specificity for internal and external nominal antigen.
Zöller M
Immunology; 1991 Nov; 74(3):407-13. PubMed ID: 1722772
[TBL] [Abstract][Full Text] [Related]
40. Granulocyte-macrophage colony-stimulating factor-cultured bone marrow-derived macrophages reveal accessory cell function and synthesis of MHC class II determinants in the absence of external stimuli.
Fischer HG; Opel B; Reske K; Reske-Kunz AB
Eur J Immunol; 1988 Aug; 18(8):1151-8. PubMed ID: 3138135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
